Location: Home
  • search
  • go
  • Relate News
  • 11/1/2018By-Health and Bioiberica Partner on New Bone Joint Care Products
  • 10/31/2018NMPA and NHC Release New Rule for Evaluation of Urgently Needed Foreig...
  • 10/30/2018NMPA Issues Two Bioequivalence Study Guidelines
  • 10/29/2018Leading Chinese Pharma Companies by R&D Spending in H1/2018
  • 10/26/2018Recent Executive Moves
  • 10/26/2018Bispecific Antibodies in China
  • 10/26/2018Green Vally Reports Positive Results in Phase 3 China Trial of Alzheim...
  • 10/26/2018111 Inc. Establishes Strategic Partnerships with Mentholatum China and...
  • 10/25/2018Alibaba and JD.com Operate in Grey Area with Online Drug Sales
  • 10/25/2018WuXi AppTec Launches Drug Screening Library
  • 10/25/2018Three Big Pharma Stocks Racing Along the Road to China
  • 10/24/2018CStone Receives USFDA IND Approval for PD-1 mAb CS1003
  • 10/24/2018Draft Amendment of the Drug Administration Law under Review by the NPC
  • 10/24/2018CANbridge and WuXi Biologics Enter into Rare Disease Partnership
  • 10/23/2018IQVIA: Chinese Retail Pharmacy Market Surged 3.9% in MAT Q2/2018
  • 10/23/2018Healthcare Sector Growth Slows in First Three Quarters of 2018
  • 10/23/2018China Is Funding the Future of American Biotech
  • 10/23/2018China Electronics Data and WuXi AppTec Form Healthcare Big Data JV
  • 10/18/2018Chi-Med Starts Phase I Study of HMPL-523 for Leukemia In China
  • 10/18/2018Recent Executive Moves
  • 10/18/2018IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q2/2018
  • 10/18/2018NHC Drafts Plan to Boost Overall Clinical Appraisal of Drug Products
  • 10/17/2018Eisai's NDA for Antiepileptic Perampanel Accepted in China
  • 10/16/2018DiaMedica and Fosun Subsidiary Signs License Agreement for Stroke Medi...
  • 10/16/2018Alphamab's HER2 Bispecific Antibody KN026 Gains US IND
  • 10/16/2018CStone Receives U.S. IND Approval for PD-L1 Antibody CS1001
  • 10/15/2018How to Fulfill China’s Potential for Carrying Out Clinical Trials
  • 10/15/2018Innovent Granted Chinese IND for Sintilimab/Bevacizumab Combinaiton Th...
  • 10/15/2018Zheijiang Huahai Placed under Increased Supervision
  • 10/15/2018Exploring Ways to Establish Presence in China as Part of APAC Region P...
  • Page:130/334 Total number of articles:9998: [First][<<] [128] [129] [130] [131] [132] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group